The CVC market is projected to grow from USD 2,861.0 million in 2024 to USD 5,436.8 million by 2034 at a CAGR of 6.6%.

and 2 mg to clear clots in central venous catheters pending the results of a study to determine the effectiveness of smaller doses.

Read about how Northern Ireland nurses are pioneering a new way of inserting catheters, to improve waiting times and patient ...

Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study ...

Servier Egypt, a leading player in the pharmaceutical industry and part of the global Servier Group, proudly marked its ...

CASCADE, Central venous Access device SeCurement And Dressing Effectiveness; PICC, Peripherally inserted central catheter; nt, non-tunnelled; t, tunnelled. Sample size estimates: A reduction in ...

What you need to know ### BMJ Learning To obtain accredited continuous professional development points, subscribers to BMJ Learning can complete the full module at The module contains seven ...

An SNP MSP who served as a nurse at the hospital nearest the site of the Lockerbie bombing has told of the moment staff ...

Poly Medicure jumped 7.91% to Rs 2,464.30 after its consolidated net profit grew 31.08% to Rs 85.23 crore on 24.92% rise in revenue from operations to Rs 424.21 crore in Q3 FY25 over Q3 FY24.

Probiotics may help with many health conditions. Although they're generally safe, it's important to talk with your doctor ...

Herbs and supplements were the most common treatment offered by the clinics (53 clinics; 45%) followed by non-antibiotic intravenous therapy (26%), unspecified antibiotics (22%), hyperbaric oxygen ...